Institutional investors purchased a net $411.3 thousand shares of BSTC during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 53.82% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RICE, HALL, JAMES & ASSOCIATES L... Bought 39.0 Thousand shares of Biospecifics Technologies...
NORTHPOINTE CAPITAL LLC Bought 37.4 Thousand shares of Biospecifics Technologies...